Katherine Thain
About Katherine Thain
Katherine Thain is a Research Scientist at Aspect Biosystems Ltd. in Vancouver, Canada, where she has worked since 2015. She holds a Ph.D. in Experimental Medicine from The University of British Columbia and specializes in 3D bioprinting of functional human tissue and the genetics of severe sepsis.
Work at Aspect Biosystems
Katherine Thain has been employed as a Research Scientist at Aspect Biosystems Ltd. since 2015. In her role, she focuses on advancing the field of 3D bioprinting, specifically in the development of functional human tissue. Her work contributes to innovative solutions in regenerative medicine and tissue engineering, aligning with the company's mission to transform healthcare through bioprinting technology.
Education and Expertise
Katherine Thain earned her Doctor of Philosophy (Ph.D.) in Experimental Medicine from The University of British Columbia, where she specialized in functional genomics from 2008 to 2013. She also holds a Bachelor of Science (Hons) in Cell and Molecular Biology from Simon Fraser University, completed from 2002 to 2008. Her academic background supports her expertise in 3D bioprinting of functional human tissue and conducting various cell biology assays.
Background
Katherine Thain began her career with co-op positions at the BC Cancer Agency and the Institute for Heart + Lung Health. Her experience at the BC Cancer Agency in 2005 provided her with foundational knowledge in cancer research. She also worked at the Institute for Heart + Lung Health from 2006 to 2007, further enhancing her research skills in a clinical environment. Her educational and early career experiences laid the groundwork for her current research focus.
Research Focus
Katherine Thain's professional focus includes the treatments and genetics of severe sepsis. Her research aims to understand the underlying mechanisms of this condition, contributing to the development of effective therapeutic strategies. This focus aligns with her expertise in cell biology and bioprinting, allowing her to explore innovative approaches to address critical health challenges.